Tharimmune, Inc. (THAR)
NASDAQ: THAR · Real-Time Price · USD
3.090
-0.100 (-3.13%)
At close: Jan 6, 2026, 4:00 PM EST
3.170
+0.080 (2.59%)
After-hours: Jan 6, 2026, 7:54 PM EST
Tharimmune Market Cap
Tharimmune has a market cap or net worth of $108.29 million as of January 6, 2026. Its market cap has increased by 3,370.03% in one year.
Market Cap
108.29M
Enterprise Value
100.87M
1-Year Change
3,370.03%
Ranking
Category
Stock Price
$3.09
Market Cap Chart
Since the IPO on January 12, 2022, Tharimmune's market cap has increased from $41.18M to $108.29M, an increase of 162.96%. That is a compound annual growth rate of 27.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 108.29M | 1.98% |
| Dec 31, 2025 | 106.19M | 2,605.01% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -89.09% |
| Jan 12, 2022 | 41.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |